Is a complete BVMF/CVSH34 research report available?

No complete published report is available for bvmf/CVSH34 (BVMF/CVSH34) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

bvmf/CVSH34 stock profile: metrics, valuation and analysis

Market cap	624.6B
Revenue (ttm)	2.1T
Net income (ttm)	25.3B
EPS (ttm)	R$19.8
P/E (trailing)	24.7x
P/E (forward)	11.7x
Dividend	R$0.91 (1.83%)
Volume	32
Beta	0.60

All BVMF/CVSH34 indicators

Market & fundamental data

Available fields

238

Groups with data

Currency

USD

Showing 238 of 238 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	BR
Employees	300,000
Employees Change	0%
Employees Change Percent	0
Enterprise value	BRL 942.5B
Exchange	Brazil Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Healthcare Plans
Last refreshed	2026-09-09
Market cap	BRL 624.6B
Price	BRL 49.28
Price currency	BRL
Rev Per Employee	8,238,270.58x
Sector	Healthcare
Sector PE	44.89
Sector PE Fwd	12.18
Sic	8000
Symbol	bvmf/CVSH34
Website	https://www.cvshealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.06%
EV Earnings	37.2x
EV/EBIT	15.25x
EV/EBITDA	9.42x
EV/FCF	15.47x
EV/Sales	0.45x
FCF yield	9.75%
Forward P/E	11.69x
P/B ratio	1.51x
P/E ratio	24.65x
P/S ratio	0.29x
PE Ratio10 Y	23.26x
PE Ratio3 Y	35.75x
PE Ratio5 Y	30.59x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	2.95%
EBITDA Margin	4.04%
FCF margin	2.9%
Gross margin	13.64%
Gross Profit	BRL 291.7B
Gross Profit Growth	10.11%
Gross Profit Growth Q	15.28%
Gross Profit Growth3 Y	1.97%
Gross Profit Growth5 Y	3.1%
Net Income	BRL 25.3B
Net Income Growth	7.92%
Net Income Growth Q	191.77%
Net Income Growth Qo Q	1.22%
Net Income Growth3 Y	18.15%
Net Income Growth5 Y	-7.45%
Pretax Margin	1.4%
Profit Margin	1.19%
Profit Per Employee	BRL 97,627
ROA	2.97
Roa5y	3.25
ROCE	7.29
ROE	6.21
Roe5y	7.3
ROIC	7.17
Roic5y	6.76

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	7.34%
Cagr1y	27.61%
Cagr3y	17.92%
Cagr5y	4.07%
Div CAGR3	4.36%
Div CAGR5	5.64%
EPS Growth	6.3
EPS Growth Q	188.8
EPS Growth Qo Q	0.43
EPS Growth3 Y	18.83
EPS Growth5 Y	-6.92
FCF Growth	145.98%
FCF Growth Q	338.3%
FCF Growth Qo Q	66.29%
FCF Growth3 Y	-12.7%
FCF Growth5 Y	0.24%
OCF Growth	95.3%
OCF Growth Q	234.48%
OCF Growth Qo Q	49.33%
OCF Growth10 Y	4.54%
OCF Growth3 Y	-10.36%
OCF Growth5 Y	0.83%
Revenue Growth	7.37x
Revenue Growth Q	7.14x
Revenue Growth Qo Q	5.61x
Revenue Growth3 Y	6.87x
Revenue Growth5 Y	8.28x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	BRL 1.61
Assets	BRL 1.3T
Cash	BRL 72.3B
Current Assets	BRL 383.2B
Current Liabilities	BRL 442.7B
Debt	BRL 395.3B
Debt EBITDA	BRL 3.87
Debt Equity	BRL 0.96
Debt FCF	BRL 6.49
Equity	BRL 413.9B
Interest Coverage	3.92
Liabilities	BRL 900.8B
Long Term Assets	BRL 931.5B
Long Term Liabilities	BRL 458.1B
Net Cash	BRL -323B
Net Cash By Market Cap	BRL -51.72
Net Debt EBITDA	BRL 3.74
Net Debt Equity	BRL 0.78
Net Debt FCF	BRL 5.3
Tangible Book Value	BRL -157.6B
Tangible Book Value Per Share	BRL -123
WACC	5.94

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.87
Inventory Turnover	20.32
Net Working Capital	BRL -112.8B
Quick ratio	0.62
Working Capital	BRL -60.6B
Working Capital Turnover	BRL -142

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.19%
Dividend Growth	0.71%
Dividend Growth Years	0%
Dividend per share	BRL 0.91
Dividend Years	11
Dividend Yield	1.83%
Ex Div Date	2026-07-22
Last Dividend	BRL 0.05
Payout Frequency	Quarterly
Payout Ratio	69.86%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	103.09%
1Y total return	27.59%
200-day SMA	44.56
3Y total return	63.98%
50-day SMA	51.75
50-day SMA vs 200-day SMA	50over200
5Y total return	22.08%
All Time High	60.8
All Time High Change	-18.36%
All Time High Date	2022-01-06
All Time Low	20.23
All Time Low Change	145.33%
All Time Low Date	2018-04-02
ATR	0.78
Beta	0.6
Ch YTD	13.49
High	49.64
High52	58.37
High52 Date	2026-07-21
High52ch	-15.57%
Low	48.56
Low52	36.78
Low52 Date	2026-03-30
Low52ch	33.99%
Ma50ch	-4.08%
Price vs 200-day SMA	11.4%
RSI	48.23
RSI Monthly	59.9
RSI Weekly	55.26
Sharpe ratio	1.17x
Sharpe Ratio3y	0.47x
Sharpe Ratio5y	0.15x
Sortino ratio	1.75
Sortino Ratio3y	0.8
Sortino Ratio5y	0.37
Total Return	0.64%
Tr YTD	15.27
Tr1m	-7.3%
Tr1w	1.99%
Tr3m	7.44%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,276,460,978%
Net Borrowing	-26,574,872,500
Shares Insiders	0.09%
Shares Institutions	90.69%
Shares Qo Q	0.63%
Shares Yo Y	1.19%
Short Ratio	2.15

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	BRL 57.2B
Adjusted OCF	72,867,952,000
Average Volume	671.5x
Bv Per Share	323.1
CAPEX	BRL -15.7B
Ch10y	62.54
Ch1m	-7.3
Ch1w	1.99
Ch1y	24.94
Ch3m	6.98
Ch3y	52.04
Ch5y	9.34
Ch6m	17.08
Change	-0.73%
Change From Open	-0.73
Close	49.64
Days Gap	0
Depreciation Amortization	22,999,344,200
Dollar Volume	1,577
Earnings Date	2026-11-04
EBIT	BRL 63B
EBITDA	BRL 86.4B
EPS	BRL 19.77
F Score	7
FCF	BRL 60.9B
FCF EV Yield	6.46x
Financing CF	-43,648,240,000
Fiscal Year End	December
Founded	1,963
Goodwill	434,749,655,800
Graham Number	38.32493
Graham Upside	-22.23
Income Tax	BRL 4.7B
Investing CF	-35,452,214,400
Is Primary Listing	0
Last Earnings Date	2026-08-05
Last Report Date	2026-06-30
Last Split Date	2022-11-21
Last Split Type	Forward
Lynch Fair Value	BRL 9.99
Lynch Upside	-79.72
Ma150	45.24
Ma150ch	9.73%
Ma20	48.93
Ma20ch	1.46%
Net CF	-2,528,230,400
Next Earnings Date	2026-11-04
Open	49.64
P FCF Ratio	10.25
P FCF Ratio SBC	10.92
P OCF Ratio	8.16
P OCF Ratio SBC	8.57
Payment Date	2026-08-07
Position In Range	66.67
Ppne	140,472,995,900
Price Date	2026-09-08
Price EBITDA	BRL 7.23
Relative Volume	0.05x
Revenue	2,137,831,216,000x
SBC By Revenue	0.17x
Share Based Comp	3,704,272,000
Tax By Revenue	0.22x
Tax Rate	15.59%
Tr6m	18.26%
Volume	32
Z Score	2.43

BVMF/CVSH34 (BVMF/CVSH34)

Price

Financial snapshot

Fair-value bridge

Latest news · BVMF/CVSH34

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BVMF/CVSH34 indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on BVMF/CVSH34

Frequently asked questions